After Britain authorized a bivalent vaccine to target Omicron, some are wondering whether they should hold out for a similar shot in the U.S.
Share this post
After Britain authorized a bivalent vaccine to target Omicron, some are wondering whether they should hold out for a similar shot in the U.S.